Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, October, 2009, Advertising

New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive:

       

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AAH (UK) N/A Corporate Euro RSCG Life
GSK UK Eumovate and Eumocream Dermatology Euro RSCG Life
Johnson & Johnson EMA Vision care Ophthalmology Euro RSCG Life
Lundbeck Cipralex Mental health MSA Digital
Lundbeck Ebixa Central nervous system MSA Digital
Merck-Serono Global N/A Fertility portfolio Euro RSCG Life
Mundipharma International  New product  Respiratory  Health 4 Brands 
Mundipharma International   New product  Pain  Health 4 Brands  
Novo Nordisk  Levemir  Diabetes  Bedgebury Communications 
Takeda  Amias  Cardiovascular  MSA Digital 
Teva  Qvar  Respiratory  MSA Digital 
Teva Nasofan Allergies MSA Digital


Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

16th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics